NASDAQ · Medical - Instruments & Supplies

LUCY (LUCY) Stock

$0.75 -3.42% NASDAQ: LUCY Healthcare

Valuation

MetricValue
Price$0.75
Market Cap$2.98M
P/E Ratio-0.51
P/B Ratio0.43
P/S Ratio1.28
EPS (TTM)$-1.90
52-Week High$2.90
52-Week Low$0.65
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-88.89%
ROA-80.00%
ROCE-88.89%
Gross Margin-266.67%
Operating Margin-266.67%
Net Margin-2.72%
Debt/Equity0.01
Current Ratio9.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$1.0M$1.0M$2.0M$3.0M
Operating Profit$-3.0M$-6.0M$-7.0M$-8.0M$-8.0M
Net Profit$-3.0M$-6.0M$-7.0M$-8.0M$-8.0M
EPS$-12.37$-17.41$-12.67$-5.19$-1.90
Op Margin-464.1%-845.2%-594.9%-484.2%-319.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$5.0M$6.0M$10.0M$10.0M
Total Liabilities$1.0M$1.0M$1.0M$1.0M$1.0M
Cash$0$4.0M$4.0M$3.0M$7.0M
Borrowings$0$0$0$0$0

Latest News

Innovative Eyewear Launches Claude AI Integration for Lucyd Smart Eyewear InvestorsHub · Jul 10, 2026 Innovative Eyewear, Inc. Announces New Claude AI Integration for All Lucyd Smart Eyewear PR Newswire · Jul 10, 2026 Innovative Eyewear, Inc. Announces Exercise of Warrants For Approximately $3.0 Million in Gross Proceeds PR Newswire · Jul 8, 2026 Innovative Eyewear, Inc. Announces 345-Store Rollout with FYihealth Group PR Newswire · Jul 7, 2026 BC-Most Active Stocks Associated Press · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-3.0M$-6.0M$-7.0M$-7.0M
Investing Cash Flow$0$0$0$-5.0M$4.0M
Financing Cash Flow$0$0$3.0M$4.0M$0
Net Cash Flow$0$4.0M$1.0M$-2.0M$4.0M
Free Cash Flow$-1.0M$-3.0M$-6.0M$-7.0M$-7.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-199.73%
Quick Ratio6.09
Interest Coverage—
Return 1Y-59.60%
Return 3Y-94.93%
Return 5Y—

Ownership

Insiders Held7.60%
Institutions Held9.03%
Institutions Float Held9.77%
Institutional HolderSharesReport Date
Cetera Investment Advisers500,0002026-03-31
Geode Capital Management, LLC60,5172026-03-31
Keybank National Association15,0002026-03-31
Tower Research Capital LLC (TRC)1,7592026-03-31
Jones Financial Companies, L.L.L.P.6142026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APRE $0.62 -1.16% -0.47 $4.06M 0.00%
BCDABioCardia, Inc. $0.84 -1.11% -0.83 $4.88M 0.00%
BMRA $1.61 +1.26% -1.09 $4.98M 0.00%
CELZ $0.79 -2.09% -1.47 $2.05M 0.00%
CHEKCheck-Cap Ltd. $1.86 +1.64% -0.43 $10.88M 0.00%

About LUCY

LUCY is led by CEO Harrison Reed Gross, employs 11 people, headquartered in US, publicly traded since 2022.

LUCY stock trades at $0.75 with a market capitalization of $2.98M. The stock is valued at a price-to-earnings (P/E) ratio of -0.51, price-to-book of 0.43, price-to-sales of 1.28. Over the past 52 weeks the stock has ranged between $0.65 and $2.90, and currently trades 74.1% below its 52-week high.

On profitability, LUCY generates a return on equity (ROE) of -88.89%, return on capital employed of -88.89%, an operating margin of -266.67%, a net profit margin of -2.72%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides